Drug Safety

Correspondence and papers relating to the safety of drugs, notably adverse reactions, safety and EEC regulations, new products, licensing fees, differences in availability of drugs in different countries, specifications for medicine containers, recording and reporting of side effects of drugs by doctors, withdrawal of arthritis drug Opren, Alfred Gibbs case and the prescribing of unlicensed drugs (death caused by injection of superglue), Depo Provera hearings (contraceptive), risks in drug taking, concerns about blood pressure pill Slow-K, review of safety of Distalgesic, new pressure group Drug Watch, safety of various arthritis drugs, drug labelling, prescribing of withdrawn drugs, safety of imported drugs, resources for medicines in the NHS.

Includes DHSS press releases, correspondence with the DHSS and pharmaceutical companies, journal and press articles, various DHSS draft proposals under the Medicines Act 1968, and Report of Committee on Safety of Medicines Working Party on Adverse Reactions 1983, with the Patients Association's comments.

Drugs mentioned in this file: phenacetin, phenylbutazone, Halcion (a benzodiazipine - triazolam), Opren (benoxaprofen), Tagamet, Tylenol, Depo Provera, Zomax, Slow-K, products containing Amygdalin, Lithium, Debendox, Zelmid, Osmosin, aspartame, Flosint tablets, thalidomide, Flenac, hydrocortisone sodium succinate injection.

1980-1985

1 file